These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 19036811)
1. Expression of vFLIP in a lentiviral vaccine vector activates NF-{kappa}B, matures dendritic cells, and increases CD8+ T-cell responses. Rowe HM; Lopes L; Brown N; Efklidou S; Smallie T; Karrar S; Kaye PM; Collins MK J Virol; 2009 Feb; 83(4):1555-62. PubMed ID: 19036811 [TBL] [Abstract][Full Text] [Related]
2. A versatile supramolecular nanoadjuvant that activates NF-κB for cancer immunotherapy. Xu Y; Wang Y; Yang Q; Liu Z; Xiao Z; Le Z; Yang Z; Yang C Theranostics; 2019; 9(11):3388-3397. PubMed ID: 31244959 [TBL] [Abstract][Full Text] [Related]
3. Checkpoint inhibitor-expressing lentiviral vaccine suppresses tumor growth in preclinical cancer models. Tada T; Norton TD; Leibowitz R; Landau NR J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38658032 [TBL] [Abstract][Full Text] [Related]
4. Immunization of mice with lentiviral vectors targeted to MHC class II+ cells is due to preferential transduction of dendritic cells in vivo. Ciré S; Da Rocha S; Yao R; Fisson S; Buchholz CJ; Collins MK; Galy A PLoS One; 2014; 9(7):e101644. PubMed ID: 25058148 [TBL] [Abstract][Full Text] [Related]
5. Pentalinonsterol, a Constituent of Pentalinon andrieuxii, Possesses Potent Immunomodulatory Activity and Primes T Cell Immune Responses. Oghumu S; Varikuti S; Saljoughian N; Terrazas C; Huntsman AC; Parinandi NL; Fuchs JR; Kinghorn AD; Satoskar AR J Nat Prod; 2017 Sep; 80(9):2515-2523. PubMed ID: 28876059 [TBL] [Abstract][Full Text] [Related]
7. A novel fluoropolymer as a protein delivery vector with robust adjuvant effect for cancer immunotherapy. Zhan YR; He X; Huang ZY; Chen P; Tian MM; Li GH; Yu XQ; Song XR; Zhang J J Mater Chem B; 2023 Sep; 11(37):8933-8942. PubMed ID: 37682063 [TBL] [Abstract][Full Text] [Related]
10. Using a prime and pull approach, lentivector vaccines expressing Ag85A induce immunogenicity but fail to induce protection against Mycobacterium bovis bacillus Calmette-Guérin challenge in mice. Britton G; MacDonald DC; Brown JS; Collins MK; Goodman AL Immunology; 2015 Oct; 146(2):264-70. PubMed ID: 26095282 [TBL] [Abstract][Full Text] [Related]
12. Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy. Escors D New J Sci; 2014 Jan; 2014():. PubMed ID: 24634791 [TBL] [Abstract][Full Text] [Related]
13. Lentiviral vectors for cancer immunotherapy and clinical applications. Liechtenstein T; Perez-Janices N; Escors D Cancers (Basel); 2013 Sep; 5(3):815-37. PubMed ID: 24078865 [TBL] [Abstract][Full Text] [Related]
14. Harnessing alveolar macrophages for sustained mucosal T-cell recall confers long-term protection to mice against lethal influenza challenge without clinical disease. Macdonald DC; Singh H; Whelan MA; Escors D; Arce F; Bottoms SE; Barclay WS; Maini M; Collins MK; Rosenberg WM Mucosal Immunol; 2014 Jan; 7(1):89-100. PubMed ID: 23715172 [TBL] [Abstract][Full Text] [Related]
15. Targeting lentiviral vectors for cancer immunotherapy. Arce F; Breckpot K; Collins M; Escors D Curr Cancer Ther Rev; 2011 Nov; 7(4):248-260. PubMed ID: 22983382 [TBL] [Abstract][Full Text] [Related]
16. MODULATING CO-STIMULATION DURING ANTIGEN PRESENTATION TO ENHANCE CANCER IMMUNOTHERAPY. Liechtenstein T; Dufait I; Lanna A; Breckpot K; Escors D Immunol Endocr Metab Agents Med Chem; 2012 Sep; 12(3):224-235. PubMed ID: 22945252 [TBL] [Abstract][Full Text] [Related]
17. Conventional dendritic cells are required for the activation of helper-dependent CD8 T cell responses to a model antigen after cutaneous vaccination with lentiviral vectors. Goold HD; Escors D; Conlan TJ; Chakraverty R; Bennett CL J Immunol; 2011 Apr; 186(8):4565-72. PubMed ID: 21389256 [TBL] [Abstract][Full Text] [Related]
18. A herpesvirus virulence factor inhibits dendritic cell maturation through protein phosphatase 1 and Ikappa B kinase. Jin H; Yan Z; Ma Y; Cao Y; He B J Virol; 2011 Apr; 85(7):3397-407. PubMed ID: 21248029 [TBL] [Abstract][Full Text] [Related]
19. Immunization delivered by lentiviral vectors for cancer and infectious diseases. Hu B; Tai A; Wang P Immunol Rev; 2011 Jan; 239(1):45-61. PubMed ID: 21198664 [TBL] [Abstract][Full Text] [Related]
20. Lentiviral vectors in gene therapy: their current status and future potential. Escors D; Breckpot K Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):107-19. PubMed ID: 20143172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]